Analyzing NeurAxis (NASDAQ:NRXS) & Edap Tms (NASDAQ:EDAP)

NeurAxis (NASDAQ:NRXSGet Free Report) and Edap Tms (NASDAQ:EDAPGet Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings.

Earnings and Valuation

This table compares NeurAxis and Edap Tms’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NeurAxis $2.68 million 6.16 -$4.78 million N/A N/A
Edap Tms $65.42 million 4.15 -$3.09 million ($0.63) -11.67

Edap Tms has higher revenue and earnings than NeurAxis.

Institutional and Insider Ownership

11.8% of NeurAxis shares are owned by institutional investors. Comparatively, 62.7% of Edap Tms shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for NeurAxis and Edap Tms, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeurAxis 0 0 1 0 3.00
Edap Tms 0 0 2 0 3.00

Edap Tms has a consensus price target of $13.67, indicating a potential upside of 85.94%. Given Edap Tms’ higher possible upside, analysts clearly believe Edap Tms is more favorable than NeurAxis.

Profitability

This table compares NeurAxis and Edap Tms’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NeurAxis N/A N/A N/A
Edap Tms -35.03% -34.16% -22.16%

Summary

Edap Tms beats NeurAxis on 6 of the 10 factors compared between the two stocks.

About NeurAxis

(Get Free Report)

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

About Edap Tms

(Get Free Report)

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Lyon, France.

Receive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with MarketBeat.com's FREE daily email newsletter.